Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 815-596-5 | CAS number: 1613307-27-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 9th September 2013 to 11th November 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- ethyl 2-(3-chloro-5-cyanophenoxy)acetate
- EC Number:
- 815-596-5
- Cas Number:
- 1613307-27-9
- Molecular formula:
- C11H11CINO3
- IUPAC Name:
- ethyl 2-(3-chloro-5-cyanophenoxy)acetate
- Test material form:
- solid: particulate/powder
1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Animals were received from Charles River, Raleigh NC and Portage MI, on 10 Sep 2013 and 17 Sep 2013. Following an acclimation period of at least five days, six healthy, non-pregnant and nulliparous female Sprague Dawley rats were assigned to treatment groups without conscious bias.
The animals were Identified by cage notation and indelible body marks, and housed in suspended wire cages; five per sex per cage prior to dosing and three per sex per cage following dosing. Absorbent paper bedding was placed beneath the cages and changed at least three times per week. Fresh PMI Rat Chow (Diet #5012) was freely available except for 16-20 hours prior to dosing. Water was available ad libitum.
The animal room, reserved exclusively for rats on acute tests, was temperature controlled, had a 12-hour light/dark cycle, and was kept clean and vermin free.
The pretest body weight range was 200 - 230 grams. The weight variation of the animals used did not exceed ±20% of the mean body weight of the previously dosed animals.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- The test article was mixed with distilled water to make dosing by gavage possible. The dose was based on the dry weight of the test article. A single dose was administered orally by syringe and dosing needle at a dose level of 2000 mg/kg to six female rats.
- Doses:
- One dose of 2000 mg/kg test material
- No. of animals per sex per dose:
- Initially three healthy female Sprague Dawley rats were dosed orally with L-005183690-000F003 at 2000 mg/kg. An additional three healthy females were dosed as a confirmatory group at 2000 mg/kg.
- Control animals:
- no
- Details on study design:
- Dosing
The test article was mixed with distilled water to make dosing by gavage possible. The dose was based on the dry weight of the test article. A single dose was administered orally by syringe and dosing needle at a dose level of 2000 mg/kg to six female rats.
Type and Frequency of Observations
In Vivo - Animals were observed at 15 minutes, 1, 2 and 4 hours postdose and once daily for 14 days for toxicity and pharmacological effects and twice daily for mortality. Body weights were recorded immediately pretest, weekly and at termination
Post Mortem - All animals were humanely sacrificed using CO2 and were examined for gross pathology following study termination.
Analysis of Data
The test article was assigned to a toxic category and an estimate of the LD50 was made based on the mortality results.
The test article was assigned to a toxic category according to the current Globally Harmonized System of Classification and Labeling of Chemicals (GHS). United Nations - New York and Geneva.
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All six female animals survived the 2000 mg/kg oral dose.
- Clinical signs:
- other: There were no abnormal physical signs observed.
- Gross pathology:
- The gross necropsy of all animals revealed no observable abnormalities.
Applicant's summary and conclusion
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- L-005183690-000F003 is considered to be in Acute Toxic Category 5, or unclassified. The oral LD50 is greater than 2000 mg/kg in female rats.
- Executive summary:
Objective: To determine the potential for oral toxicity using the Acute Toxic Class Determination. This study was designed to comply with the standards set forth in the current OECD Guidelines for the Testing of Chemicals, Guideline 423. Guideline 423 is referred to in OPPTS 870.1000 as an acceptable method to assess lethality within a dose range. The test article was assigned to a toxic category based on the
mortality results and significant clinical signs of toxicity up to the Category 4 value tested according to the current Globally Harmonized System of Classification and Labeling of Chemicals (GHS).
Method Synopsis: Initially three healthy female Sprague Dawley rats were dosed orally with L-005183690-000F003 at 2000 mg/kg. An additional three healthy females were dosed as a confirmatory group at 2000 mg/kg. The rats were observed at 15 minutes, 1, 2 and 4 hours postdose and once daily for 14 days for toxicity and pharmacological effects, and twice daily for mortality. Body weights were recorded immediately pretest, weekly and at termination. All animals were examined for gross pathology.
The test article was assigned to a toxic category based on the mortality response noted.
Summary:
All six female animals survived the 2000 mg/kg oral dose.
There were no abnormal physical signs observed.
All animals gained body weight by study termination; one animal lost weight between Days 7 and 14.
The gross necropsy of all animals revealed no observable abnormalities.
Conclusion: L-005183690-000F003 is considered to be in Acute Toxic Category 5, or unclassified The oral LD50 is greater than 2000 mg/kg in female rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.